Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLOXNASDAQ:HUGEOTCMKTS:OCQLFNASDAQ:SAAS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLOX(BLOX)$21.12+2.6%$0.00$13.22▼$26.50N/AN/A1.23 million shs6,746 shsHUGEFSD Pharma$0.23$0.11$0.07▼$1.68$9.11M0.610.14 million shsN/AOCQLF01 Communique Laboratory$0.28+0.9%$0.24$0.05▼$0.22N/AN/A5,680 shs114,181 shsSAAS(SAAS)$0.01$0.00$7.15▼$13.99N/AN/A1.05 million shs200,000 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLOX(BLOX)0.00%+6.69%-22.19%-22.19%-22.19%HUGEFSD Pharma0.00%0.00%0.00%+152.50%+40.12%OCQLF01 Communique Laboratory0.00%-1.76%+22.36%+49.73%+709.86%SAAS(SAAS)0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLOX(BLOX)N/AN/AN/AN/AN/AN/AN/AN/AHUGEFSD PharmaN/AN/AN/AN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLOX(BLOX) 0.00N/AN/AN/AHUGEFSD Pharma 0.00N/AN/AN/AOCQLF01 Communique Laboratory 0.00N/AN/AN/ASAAS(SAAS) 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLOX(BLOX)N/AN/AN/AN/AN/AN/AHUGEFSD PharmaN/AN/AN/AN/A$0.33 per shareN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLOX(BLOX)N/AN/A0.00∞N/AN/AN/AN/AN/AHUGEFSD Pharma-$17.90M-$0.26N/AN/AN/AN/A-74.06%-55.31%N/AOCQLF01 Communique LaboratoryN/AN/A0.00∞N/AN/AN/AN/AN/ASAAS(SAAS)N/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLOX(BLOX)N/AN/AN/AN/AN/AHUGEFSD PharmaN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLOX(BLOX)N/AN/AN/AHUGEFSD PharmaN/A2.342.34OCQLF01 Communique LaboratoryN/AN/AN/ASAAS(SAAS)N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLOX(BLOX)93.93%HUGEFSD Pharma1.24%OCQLF01 Communique LaboratoryN/ASAAS(SAAS)93.53%Insider OwnershipCompanyInsider OwnershipBLOX(BLOX)3.20%HUGEFSD Pharma8.53%OCQLF01 Communique LaboratoryN/ASAAS(SAAS)6.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLOX(BLOX)N/AN/AN/ANot OptionableHUGEFSD Pharma1740.12 million36.70 millionOptionableOCQLF01 Communique LaboratoryN/AN/AN/ANot OptionableSAAS(SAAS)N/AN/AN/ANot OptionableHUGE, BLOX, SAAS, and OCQLF HeadlinesRecent News About These CompaniesSmriti Irani on why 'Kyunki Saas Bhi Kabhi Bahu Thi 2' is delayed: 'I got a call from Prime Minister's office and...'July 1 at 11:25 AM | firstpost.comFKyunki Saas Bhi 2 premiere postponed, here’s whyJuly 1 at 11:25 AM | msn.comWhat is a platform? The state and local tax answerJuly 1 at 3:23 AM | thetaxadviser.comTInfrasity Engineers a New Era of Developer-First Content, Scaling SaaS Adoption Across the US, EU, and IsraelJuly 1 at 3:23 AM | theprint.inTThe Enterprise SaaS Pricing Blind Spot: Why Willingness To Pay Is So Hard To Get RightJuly 1 at 3:23 AM | forbes.comSmriti Irani Reveals Rejecting Rishi Kapoor's Film & Kyunki Saas Bhi Kabhi Bahu Thi 2 In 2014: 'Got A Call From PM's Office'June 30 at 3:36 AM | msn.comKyunki Saas Bhi Kabhi Bahu Thi to go on floors from July 3, after shoot was halted due to Vastu concerns (Exclusive)June 30 at 3:36 AM | msn.comSmriti Irani, Amar Upadhyay's Kyunki Saas Bhi...2 premiere postponed. Here's whyJune 30 at 3:36 AM | msn.comKyunki Saas Bhi Kabhi Bahu Thi 2 launch delayed, Amar Upadhyay says 'Ektaa knows exactly what she wants'June 30 at 3:36 AM | moneycontrol.comSaaS Architecture Unveiled: Building a Scalable Social Casino PlatformJune 29 at 8:35 AM | techstory.inTWhy the next great SaaS infrastructure will be built in India, not CaliforniaJune 28 at 5:36 AM | financialexpress.comFFrom Air Force to SaaS: How Alex Becker Became a Serial EntrepreneurJune 27, 2025 | tribuneindia.comTHow to Investigate Suspicious User Activity Across Multiple SaaS ApplicationsJune 27, 2025 | securityboulevard.comSHow To Build A High-Growth SaaS MarketplaceJune 27, 2025 | forbes.comHow To Build A High-Growth SaaS MarketplaceJune 27, 2025 | forbes.comWhy TiDB is the ideal database for next-gen SaaS platformsJune 26, 2025 | yourstory.comYnOAuth Vulnerability Still Affects 9% of Microsoft Entra SaaS Apps Two Years After DiscoveryJune 25, 2025 | thehackernews.comTThousands of SaaS Apps Could Still Be Susceptible to nOAuthJune 25, 2025 | securityweek.comSReport: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS SprawlJune 25, 2025 | finance.yahoo.comKorean SaaS Startups Make Strategic U.S. Push at Washington Innovation SummitJune 25, 2025 | finance.yahoo.comMedia Sentiment Over TimeTop HeadlinesView All Headlines2 Under the Radar Space & Defense Stocks With Huge PotentialBy Leo Miller | July 1, 2025View 2 Under the Radar Space & Defense Stocks With Huge PotentialBroadcom’s Big VMware Update: A Threat to Public Cloud Giants?By Leo Miller | June 28, 2025View Broadcom’s Big VMware Update: A Threat to Public Cloud Giants?Regional Bank Buybacks: 5 Institutions Making Big MovesBy Leo Miller | June 24, 2025View Regional Bank Buybacks: 5 Institutions Making Big Moves3 Auto Chip Stocks Up 60%+ From 2025 Lows: More Gains Ahead?By Leo Miller | June 18, 2025View 3 Auto Chip Stocks Up 60%+ From 2025 Lows: More Gains Ahead?Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?By Leo Miller | June 28, 2025View Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?HUGE, BLOX, SAAS, and OCQLF Company Descriptions(BLOX) NYSE:BLOXInfoblox Inc. (Infoblox) is a United States-based company, which delivers Actionable Network Intelligence to enterprise, government and service provider customers across the world. The Company's products include core network services, such as domain name system (DNS), dynamic host configuration protocol (DHCP), Internet protocol address manager (IPAM) data documentation initiative (DDI); Private Cloud/Virtualization; Public/Hybrid Cloud; Reporting and Analytics, and Network Insight. Its products also include DNS, such as DNS Firewall, Advanced DNS Protection, Threat Insight and Active Trust, and network automation, such as NetMRI. Its solutions include information technology (IT) compliance and digital economy. It offers solutions for Microsoft and Infoblox, Internet protocol version 6 (IPv6) readiness and cybersecurity ecosystem. It supports offerings, such as Infoblox BloxCare Premium and Elite Maintenance programs, as well as its optional Technical Account Manager service.FSD Pharma NASDAQ:HUGEFSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.01 Communique Laboratory OTCMKTS:OCQLF$0.28 +0.00 (+0.90%) As of 06/27/202501 Communique Laboratory, Inc. develops and markets remote access solutions. The Company's solutions consist of I'm InTouch, I'm OnCall and I'm InTouch Meeting product lines, which provide users with the ability to conduct online meetings. 01 Communique Laboratory was founded on October 7, 1992 and is headquartered in Toronto, Canada.(SAAS) NASDAQ:SAASinContact, Inc. (inContact) is a provider of cloud contact center software solutions. The Company provides a range of cloud contact center call routing, self-service and agent optimization solutions. The Company operates through two business segments: Software and Network connectivity. inContact's Software segment includes the services related to the delivery of its cloud contact center software solutions. Its Network connectivity segment includes the voice and data long distance services provided to customers. It offers its products and services to its customers in approximately five vertical markets, such as customer services and sales business process outsourcers (BPOs), retail and direct response, healthcare providers, utilities, and state and local Government. It provides software, which includes Automatic call distributing, Computer telephony integration, Interactive voice response with speech recognition, Outbound dialer, Screen recording and Interactive reporting tool. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
